Maiwald Magazine

News and Releases

Maiwald Blog

26 May 2025 - Maiwald Blog

Turn one into several – what Rule 80 EPC says about using several independent claims to defend one independent claim

The Board of Appeal of the EPO has issued two decisions concerning appeal cases T 0123/22 and T 1191/22, which relate to the interpretation of Rule 80 EPC. The fundamental que...

Continue reading

11 Apr 2025 - Maiwald Blog

EPO Board of Appeal 3.3.04 is setting the right standard for acknowledging novelty of non-medical use claims (T 1913/21)

G 2/88 provides legal assessment for novelty of a non-medical use claim. G 2/88 allows acknowledging novelty of a non-medical use claim of an old compound for a particular pur...

Continue reading

8 Apr 2025 - Maiwald Blog

EPO revokes Roche’s Patent on combination therapy of bevacizumab and paclitaxel for platinum-resistant ovarian cancer that was supported by results of Phase III AURELIA clinical trial

European Patent EP 2 825 558 concerns a combination therapy of bevacizumab and paclitaxel for platinum-resistant ovarian cancer. The claim was supported by Phase III AURELIA c...

Continue reading

All articles

Press Coverage

15 Apr 2025 - Pressebericht

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

Cyprumed GmbH and Merck & Co., Inc. have entered a Non-Exclusive License and Option Agreement to develop oral formulations of peptides using Cyprumed’s drug delivery technology. MSD gains global non-exclusive rights...

Continue reading

2 Apr 2025 - Pressebericht

Managing IP names Maiwald one of the leading IP law firms in Germany

The market analysis by Managing IP and the IP STARS ranking 2024 confirm this: The German market for intellectual property remains dynamic and highly competitive. Especially in the field of patent law, numerous law firms were able to maintain and expand their leading positio...

Continue reading

25 Mar 2025 - Pressemitteilung

Roche gets Illumina unit’s DNA testing patent revoked

A European Patent Office board of appeal said in a ruling published on March 10th that Roche Diagnostics GmbH proved Verinata Health Inc.'s blueprint lacks an inventive step over an earlier international patent application setting out a similar way of testing "free-floating ...

Continue reading

Maiwald in the press

Staff News

4 Feb 2025 - Personalnachricht

Maiwald congratulates Dr. Anna Closs on passing the exam

We congratulate Dr. Anna Closs on passing the German patent attorney examination!

Continue reading

8 Jan 2025 - Personalnachricht

Maiwald appoints Dr. Lukas Delvos and Dr. Jian Sun as Counsel

Effective January 1, 2025, Maiwald, one of Germany's leading intellectual property law firms, appointed two new Counsel, Dr. Lukas Delvos and Dr. Jian Sun. Lukas Delvos until ...

Continue reading

29 Nov 2024 - Personalnachricht

Maiwald congratulates on passing the exam

We would like to congratulate

Continue reading

All Staff News

Publications

30 Apr 2025 - Publikation

Safe Harbor Provision in European Patent LawThe Research & Bolar Exemptions, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

This article covers the most recent developments regarding the European Research Exemption, which permits the use of patented inventions for research purposes, as well as the ...

Continue reading

30 Apr 2025 - Publikation

The ‘long-arm’ of the Unified Patent Court – New developments in European cross-border patent litigation, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

The jurisdictional reach of the Unified Patent Court (UPC) was a widely and controversially discussed topic from the outset. Some practitioners took the view that the UPC also...

Continue reading

22 Apr 2025 - Publikation

MAIinsight Issue 2 out now!

Continue reading

All publications

Awards

30 May 2025 - Auszeichnung

IP STARS 2025: Maiwald Secures Recognition for Trademark Expertise

We are delighted that Maiwald has again been ranked in Tier 3 for trademark law by Managing Intellectual Property (MIP). This ranking highlights law firms that are recommended...

Continue reading

30 May 2025 - Auszeichnung

IAM Patent 100 Rankings 2025

Continue reading

30 May 2025 - Auszeichnung

Dr.-Ing. Sophie Ertl once again ranked among the Top 250 Women in IP by Managing IP!

Congratulations to

Continue reading

All awards

Events

Wed.

21

21 May 2025 |Past Event|External Events

C5’s 18th Annual Forum on “Pharma & Biotech Patent Litigation in Europe” in Amsterdam

We are pleased to announce that Dr. Eva Susanne Ehlich will be an expert at the 18th C5 Communications Forum on “Pharma & Biotech Patent Litigation in Europe” in Amsterdam. Eva will give a presentation on “Plausibility and Post-Publicatio...

Continue reading

Sat.

17

17 May 2025 |Past Event|External Events

Maiwald at INTA’s 2025 Annual Meeting in San Diego

The International Trademark Association's (INTA) Annual Meeting took place in San Diego from May 17 to 21 this year. Maiwald was among the many companies and law firms in attendance, represented by Susanna Heurung,

Continue reading

Thu.

15

15 May 2025 |Past Event|SeminarSeminar

Maiwald Seminar on May 15

Patent law news: EPO case law, software and UPC (Lectures will be held in German) On May 15, we had the pleasure of hosting another Maiwald seminar in our office. Thank you to the speakers and everyone involved for making this an interesting afternoon and ensuring the event ran smoothly.

Continue reading

Tue.

6

6 May 2025 |Past Event|External Events

Maiwald at the LSPN North America Spring 2025 in Boston, May 6-7, 2025

Maiwald is joining one of the most influential IP conference in the life sciencesThe annual Life Sciences Patent Network (LSPN) Spring Conference in North America is an important meeting place for gaining innovative insights into the challenges of intellectual property in the pharmaceutical, biotechnology, and medical device industries.

Continue reading

All events